Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study
This prospective, observational study looked 10 women with subnephrotic proliferative lupus nephritis who relapsed on maintenance MMF or Imuran. They were treated with 4 weekly infusions of rituximab combined with MMF and prednisolone. This combination was found to have low toxicity and 7 patients were found to have a complete remission. This seems to warrant further study in a randomized controlled trial.
- Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
- Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis
- Treatment of severe alcoholic hepatitis with corticosteroids and pentoxifylline.